Top

Published in:

01-10-2019 | Capsule Commentary

Capsule Commentary on Baumgartner et al., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism after Knee or Hip Arthroplasty: a Large Retrospective Cohort Study

Author: Gregory J. Misky, MD

Published in: Journal of General Internal Medicine | Issue 10/2019

Excerpt

Baumgartner et al. examined the prophylactic practices of elective primary hip and knee arthroplasties over 2 years, comparing aspirin with other pharmacologic agents in preventing venous thromboembolism (VTE).¹ As might be expected, based upon the most recent American College of Chest Physician (ACCP) guidelines that includes aspirin (ASA) as an acceptable pharmacologic alternative in VTE prophylaxis, use of aspirin in this patient population has increased over time.² And despite this increase in postoperative joint patients receiving aspirin only (vs. other agents), no increase in clinically significant venous thromboembolism was identified out to 90 days. …

Baumgartner C, Maselli J, Auerbach A, Fang M. Aspirin Compared to Anticoagulation to Prevent Venous Thromboembolism after Knee or Hip Arthroplasty: A Large Retrospective Cohort Study. J Gen Intern Med 5122

Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e278S–325SCrossRef

Chu J, Maselli J, Auerbach A, Fang M. The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty. Thromb Res 155: 65–72. 2017CrossRef

Vincent V.G. et al. Aspirin as Thromboprophylaxis in Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis. J Arthroplast 31: 2608–2616. 2017

Anderson D.R. et al. Aspirin or Rivaroxaban for VTE Prophylaxis after Hip of Knee Arthroplasty. N Engl J Med 378:8. 2018

Title: Capsule Commentary on Baumgartner et al., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism after Knee or Hip Arthroplasty: a Large Retrospective Cohort Study
Author: Gregory J. Misky, MD
Publication date: 01-10-2019
Publisher: Springer International Publishing
Published in: Journal of General Internal Medicine / Issue 10/2019
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-019-05170-9

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Capsule Commentary on Baumgartner et al., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism after Knee or Hip Arthroplasty: a Large Retrospective Cohort Study

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 10/2019

Survey of Adult Influenza Vaccination Practices and Perspectives Among US Primary Care Providers (2016–2017 Influenza Season)

Lack of Association Between Meteorological Factors and Internal Medicine Admissions in New Orleans: Residents Perceptions Differ

Physician Empathy and Diabetes Outcomes

Healthcare Experiences of Transgender People of Color

Capsule Commentary on Zueger et al., Older Medicare Beneficiaries Frequently Continue Medications with Limited Benefit Following Hospice Admission

The Cardiovascular Health Burdens of Solitary Confinement

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page